OneMedNet announced a significant increase in FY26 YTD bookings, reaching approximately $16.2 million, a 1,600% year-over-year increase. This growth is driven by both new customer acquisition and expansion from existing clients, supported by substantial improvements in order fulfillment speed, indicating strong operational efficiency and market demand for their data platform.
OneMedNet reported a substantial 1,600% year-over-year increase in FY26 YTD bookings, reaching $16.2 million. This significant growth is a strong indicator of increasing demand for their iRWD™ Platform, driven by both new customer acquisition (50% of new contracts) and expansion from existing clients. The company also highlighted a 50X improvement in order fulfillment speed, which allows them to handle larger orders and deliver faster, enhancing their competitive advantage. This news is a major positive catalyst for OneMedNet, suggesting strong revenue growth potential and improved operational efficiency. For traders, this indicates a potential upside for ONMD stock in the short to medium term, as the company demonstrates strong execution and market penetration in the life sciences, medical device, and AI sectors.